Continuous-infusion topotecan and erlotinib: A study in topotecan-pretreated ovarian cancer assessing shed collagen epitopes as amarker of invasiveness
Research output: Contribution to journal › Article › peer-review
5Scopus
citations
Fingerprint
Dive into the research topics of 'Continuous-infusion topotecan and erlotinib: A study in topotecan-pretreated ovarian cancer assessing shed collagen epitopes as amarker of invasiveness'. Together they form a unique fingerprint.